@Article{, title={Evaluation of Osteocalcin and Some Biochemical Marker in Diabetes Mellitus Iraqi Women's patients with Osteoporosis}, author={Abeer Abaas Jafar and Bushra Hameed Ali}, journal={Ibn Al-Haitham Journal For Pure and Applied Sciences مجلة ابن الهيثم للعلوم الصرفة والتطبيقية}, volume={36}, number={1}, pages={225-235}, year={2023}, abstract={Diabetes mellitus is a set of metabolic diseases, the most prevalent of which is chronic hyperglycemia. The culprits include insulin synthesis, insulin action, or both. Osteoporosis is a progressive systemic skeletal disorder defined by decreased bone mass and micro architectural degeneration of bone tissue, resulting in increased bone fragility and fracture risk, according to the World Health Organization (WHO). The degree of Nervosa damage determines how much a diabetic patient's body has been compromised. The current study's goal is an estimation: Age, BMI, FBS, HbA1C, D3, ALP, Ca, P, and Osteocalcin in Iraqi T2DM Women's patients with and without Osteoporosis. Three vitamins are required for Osteocalcin biosynthesis: vitamin K for Gla formation, vitamin C for hydroxylation of Pro-9 to hydroxyproline, and vitamin D for Osteocalcin production stimulation. Vitamin D is known to function in calcium homeostasis and bone metabolism .Osteocalcin is a hormone produced by osteoblasts and secreted into the extracellular matrix of bone and the bloodstream. It serves as a biological marker for bone formation. The work was classified into three groups. G1 (n= 40) is the control set that wentto the Iraqi Ministry of Health's Endocrinology and Diabetes Center in Baghdad. G2 (n= 40) are patients with type 2 diabetes mellitus without Osteoporosis who visited the Endocrinology and Diabetes Center of the Iraqi Ministry of Health in Baghdad, and G3(n= 40) are patients with type 2 diabetes Mellitus with Osteoporosis.

} }